CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,604 | +28.6% | 23,600 | 0.0% | 0.00% | – |
| Q2 2023 | $34,692 | -24.9% | 23,600 | -0.4% | 0.00% | – |
| Q1 2023 | $46,215 | -16.2% | 23,700 | -3.3% | 0.00% | – |
| Q4 2022 | $55,125 | -8.1% | 24,500 | -0.8% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 24,700 | -28.6% | 0.00% | – |
| Q2 2022 | $72,000 | -75.4% | 34,592 | -66.7% | 0.00% | -100.0% |
| Q1 2022 | $293,000 | +72.4% | 103,818 | +184.4% | 0.00% | – |
| Q4 2021 | $170,000 | -14.1% | 36,500 | -6.4% | 0.00% | -100.0% |
| Q4 2013 | $198,000 | +15.1% | 39,000 | +3.4% | 0.00% | 0.0% |
| Q3 2013 | $172,000 | +42.1% | 37,700 | +59.7% | 0.00% | 0.0% |
| Q2 2013 | $121,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |